Prevention of CV outcomes in antihyperglycaemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, ASCVD: to start or not to start with metformin

European Heart Journal

18 November 2020
Organised by: Logo
ESC Journals CARDIOVASCULAR PHARMACOLOGY PREVENTIVE CARDIOLOGY Risk Factors and Prevention Pharmacology and Pharmacotherapy

Contributors

Naveed Sattar
Naveed Sattar

Author

University of Glasgow Glasgow , United Kingdom of Great Britain & Northern Ireland

Darren K McGuire
Darren K McGuire

Author

University of Texas Southwestern Medical Center Dallas , United States of America